These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 19403470)

  • 1. Recognition of a Kawasaki disease shock syndrome.
    Kanegaye JT; Wilder MS; Molkara D; Frazer JR; Pancheri J; Tremoulet AH; Watson VE; Best BM; Burns JC
    Pediatrics; 2009 May; 123(5):e783-9. PubMed ID: 19403470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.
    Chen PS; Chi H; Huang FY; Peng CC; Chen MR; Chiu NC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):43-50. PubMed ID: 23927822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between left ventricular ejection fraction and Kawasaki disease shock syndrome.
    Qiu H; Li C; He Y; Weng F; Shi H; Pan L; Guo Y; Zhang Y; Wu R; Chu M
    Cardiol Young; 2019 Feb; 29(2):178-184. PubMed ID: 30785384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Describing Kawasaki shock syndrome: results from a retrospective study and literature review.
    Taddio A; Rossi ED; Monasta L; Pastore S; Tommasini A; Lepore L; Bronzetti G; Marrani E; Mottolese BD; Simonini G; Cimaz R; Ventura A
    Clin Rheumatol; 2017 Jan; 36(1):223-228. PubMed ID: 27230223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Manifestations of Kawasaki Disease Shock Syndrome.
    Ma L; Zhang YY; Yu HG
    Clin Pediatr (Phila); 2018 Apr; 57(4):428-435. PubMed ID: 28905639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
    Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
    Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kawasaki Disease Shock Syndrome Versus Septic Shock: Early Differentiating Features Despite Overlapping Clinical Profiles.
    Power A; Runeckles K; Manlhiot C; Dragulescu A; Guerguerian AM; McCrindle BW
    J Pediatr; 2021 Apr; 231():162-167. PubMed ID: 33290811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoronary inflammation in Kawasaki disease is associated with abnormal myocardial deformation in the acute phase.
    Gaur L; Waloff K; Schiller O; Sable CA; Frank LH
    J Am Soc Echocardiogr; 2014 Dec; 27(12):1329-35. PubMed ID: 25479899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kawasaki disease shock syndrome: a case report].
    Vieni G; Pusceddu S; Bruno I; Ragni L; Marchetti F
    G Ital Cardiol (Rome); 2018 Feb; 19(2):111-114. PubMed ID: 29531383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children.
    Gámez-González LB; Murata C; Muñoz-Ramírez M; Yamazaki-Nakashimada M
    Eur J Pediatr; 2013 Mar; 172(3):337-42. PubMed ID: 23152158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kawasaki shock syndrome complicating a recurrence of Kawasaki disease.
    Tissandier C; Lang M; Lusson JR; Bœuf B; Merlin E; Dauphin C
    Pediatrics; 2014 Dec; 134(6):e1695-9. PubMed ID: 25384485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki disease shock syndrome: a rare and severe complication of Kawasaki disease.
    Çakan M; Gemici H; Aktay-Ayaz N; Keskindemirci G; Bornaun H; İkizoğlu T; Çeliker A
    Turk J Pediatr; 2016; 58(4):415-418. PubMed ID: 28276216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Giant coronary aneurysms in infant with Kawasaki disease shock syndrome].
    García-Domínguez M; Riviera-Navarro D; Quibrera J; Pérez-Gaxiola G
    Rev Alerg Mex; 2020; 67(2):174-182. PubMed ID: 32892531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C.
    Deng YB; Li TL; Xiang HJ; Chang Q; Li CL
    Pediatr Infect Dis J; 2003 Jan; 22(1):34-9. PubMed ID: 12544406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective follow-up cardiac evaluation of children with Kawasaki disease in Northern India using the Japanese echocardiography criteria.
    Kothur K; Singh S; Sharma Y; Mittal BR
    J Cardiol; 2007 Nov; 50(5):299-307. PubMed ID: 18044459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
    Patel A; Holman RC; Callinan LS; Sreenivasan N; Schonberger LB; Fischer TK; Belay ED
    Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
    Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of coronary flow velocity dynamics and flow reserve in patients with Kawasaki disease by means of a Doppler guide wire.
    Hamaoka K; Onouchi Z; Kamiya Y; Sakata K
    J Am Coll Cardiol; 1998 Mar; 31(4):833-40. PubMed ID: 9525556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.